Frontline Clofarabine and Cytarabine combination for plasmocytoid blastic dendritic cell neoplasm
暂无分享,去创建一个
J. Tamburini | D. Bouscary | É. Aslangul | R. Birsen | N. Chapuis | T. Szwebel | V. Bardet | S. Mathis | B. Deau | Stéphanie Mathis
[1] J. Cigudosa,et al. Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm , 2014, Leukemia.
[2] T. Petrella,et al. Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients , 2013, The British journal of dermatology.
[3] R. Hills,et al. Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival. , 2013, Blood.
[4] R. Mahfouz,et al. Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[5] L. Cerroni,et al. Unrelated SCT induces long-term remission in patients with blastic plasmacytoid dendritic cell neoplasm , 2013, Bone Marrow Transplantation.
[6] S. Pileri,et al. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study , 2013, Haematologica.
[7] F. Jardin,et al. Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. , 2011, Blood.
[8] R. Collins,et al. Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I Trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] A. Krämer,et al. Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[10] R. Hills,et al. European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] S. Pileri,et al. Novel markers of normal and neoplastic human plasmacytoid dendritic cells. , 2008, Blood.
[12] T. Rüdiger,et al. What is CD4+CD56+ malignancy and how should it be treated? , 2003, Bone Marrow Transplantation.
[13] M. Callanan,et al. CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique. , 2002, Blood.
[14] B. Drénou,et al. Clinical and biologic features of CD4(+)CD56(+) malignancies. , 2002, Blood.